Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/22/2007WO2007133798A2 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
11/22/2007WO2007133794A2 Hydrogen-producing fuel cell systems with load-responsive feedstock delivery systems
11/22/2007WO2007133792A2 Digital equalization of multiple interleaved analog-to-digital converters
11/22/2007WO2007133790A2 NF-ϰB INHIBITORS AND USES THEREOF
11/22/2007WO2007133789A2 Customer facing interface power cycling of wireless terminals
11/22/2007WO2007133788A2 Dynamic vlans in wireless networks
11/22/2007WO2007133786A2 Dynamic vlan ip network entry
11/22/2007WO2007133771A2 Multipurpose adiabatic potable water production apparatus and methods
11/22/2007WO2007133770A2 Improved automated exchange for the efficient assignment of audience items
11/22/2007WO2007133766A2 Electrically-pumped (ga,in, ai) n vertical-cavity surface-emitting laser
11/22/2007WO2007133749A2 Methods and compositions for treating and preventing peripheral nerve damage
11/22/2007WO2007133624A2 A device and method to synchronize the motion of two robots that have independent control systems
11/22/2007WO2007133622A2 Selective inhibitors of rock protein kinase and uses thereof
11/22/2007WO2007133588A2 Modified chalcone compounds as antimitotic agents
11/22/2007WO2007133491A1 Substituted spirocyclic cgrp receptor antagonists
11/22/2007WO2007133261A1 Mucosal formulation
11/22/2007WO2007133211A1 3,4-disubstituted coumarin and quinolone compounds
11/22/2007WO2007133155A1 Nicotinic acetylcholine receptor ligands 101
11/22/2007WO2007133141A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007WO2007133140A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007WO2007133112A1 Noscapine derivatives (variants), combinatory and focused library, pharmaceutical composition, methods for the production (variants) and the use thereof
11/22/2007WO2007133108A1 Pharmaceutical composition, method for the production and the use thereof
11/22/2007WO2007133090A1 Contrast agents
11/22/2007WO2007133082A1 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
11/22/2007WO2007133076A2 Mannitol and/or proline for prevention and treatment of ageing related symptoms
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132947A1 Bcl-xL TRANSGENIC ANIMAL AND UTILIZATION OF THE SAME
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132937A1 NOVEL ANTIBIOTICS, BISPOLIDES A1, A2 AND A3 AND BISPOLIDES B1, B2a, B2b AND B3 AND METHOD FOR PRODUCING THE ANTIBIOTICS
11/22/2007WO2007132906A1 Benzylamine derivatives as cetp inhibitors
11/22/2007WO2007132900A1 Skin moisturizer and therapeutic agent for dermatitis
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007132888A1 Smooth muscle contraction inhibitor
11/22/2007WO2007132873A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof
11/22/2007WO2007132867A1 Prophylactic and therapeutic agent for cancer
11/22/2007WO2007132852A1 Poorly-water-soluble pharmaceutical agent
11/22/2007WO2007132846A1 Compound having acidic group which may be protected, and use thereof
11/22/2007WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007WO2007132831A1 Method of producing s-adenosyl-l-methionine-containing dry yeast having excellent storage stability, the product thereof and composition for oral intake
11/22/2007WO2007132828A1 Method of producing nanoparticle dispersion of medicinal component
11/22/2007WO2007132825A1 Pharmaceutical agent
11/22/2007WO2007132807A1 Antiperiodontitis agents, and drinks, foods or oral hygiene products containing the agents
11/22/2007WO2007132801A1 Stent
11/22/2007WO2007132784A1 Antipsychotic drug and remedy for cognitive abnormality containing anthraquinone derivative as the active ingredient
11/22/2007WO2007132718A1 Solid preparation comprising adenosine 5'-triphosphate or physiologically acceptable salt thereof
11/22/2007WO2007132714A1 Agent for increasing bone density
11/22/2007WO2007132710A1 Bactericidal/preservative agent
11/22/2007WO2007132546A1 Pharmaceutical containing thiazole derivative as active ingredient
11/22/2007WO2007132537A1 Novel k04-0144 substances and process for production thereof
11/22/2007WO2007132496A1 Dioxaspiroketal derivatives, process for their preparation and uses thereof
11/22/2007WO2007132479A1 Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
11/22/2007WO2007132472A1 A crystalline form b4 of atorvastatin magnesium and a process thereof
11/22/2007WO2007132438A2 Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative
11/22/2007WO2007132418A1 The use of the salicylate as an antidote for paraquat intoxications in mammals
11/22/2007WO2007132328A2 Novel galenic forms of artemisin and its derivatives in combination with other antimalarial agents for treating malaria
11/22/2007WO2007132308A1 Triazolopyrazine derivatives useful as anti-cancer agents
11/22/2007WO2007132307A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007WO2007132296A2 Multilayer tablet
11/22/2007WO2007132280A1 Isatin and its derivatives for use as a medicament
11/22/2007WO2007132234A1 Pharmaceutical compositions comprising 5-aminolevulinic acid
11/22/2007WO2007132228A1 Combination of cndac with a 2-substituted-4-heter0aryl-pyrimidine amine and use thereof in the treatment of a proliferative disorder
11/22/2007WO2007132227A1 Maleate co-crystal of azd1152
11/22/2007WO2007132221A1 Combined anticancer pyrimidine-thiazole aurora kinase inhibitors
11/22/2007WO2007132220A1 Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder
11/22/2007WO2007132215A1 Combination therapy for the treatment of cancer
11/22/2007WO2007132190A1 Composition for the treatment of resistant cancers comprising oridonin
11/22/2007WO2007132179A2 Therapeutics comprising pyridinium derivatives
11/22/2007WO2007132171A1 Pharmaceutical compounds
11/22/2007WO2007132146A1 Dhfr enzyme inhibitors
11/22/2007WO2007132138A1 Pharmaceutically acceptable salts and polymorphic forms
11/22/2007WO2007132134A2 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
11/22/2007WO2007132091A1 New form of administration of racecadotril
11/22/2007WO2007132010A1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
11/22/2007WO2007131996A1 Meta-xylylenediamine vanadate salts
11/22/2007WO2007131991A1 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/22/2007WO2007131973A2 Compositions and methods for modulating the immune system
11/22/2007WO2007131930A1 Tablet formulation comprising repaglinide and metformin
11/22/2007WO2007131907A2 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
11/22/2007WO2007131846A1 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
11/22/2007WO2007131813A1 Condensation products, method for their production and use thereof in medicaments, as disinfectants or as a tannin
11/22/2007WO2007131811A1 Mixtures of tannins, their production and use in medicaments or as disinfectants
11/22/2007WO2007131805A1 Use of drospirenone for preventing high blood pressure in prehypertensive patients
11/22/2007WO2007131804A1 Tablet composition with a prolonged release of tamsulosin
11/22/2007WO2007131767A2 Novel actives against prostate carcinoma
11/22/2007WO2007131764A2 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007WO2007131737A2 Medication against breast cancer and related diseases
11/22/2007WO2007131736A2 Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
11/22/2007WO2007131689A2 Pharmaceutical combinations comprising a mtor inhibitor and a raf kinase inhibitor
11/22/2007WO2007131622A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
11/22/2007WO2007131621A1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007WO2007131620A1 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007WO2007131619A1 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007WO2007131601A1 A process for the preparation of a taxane derivative
11/22/2007WO2007131592A1 Combinations of erdosteine and beta-2 agonists for treating copd
11/22/2007WO2007131546A1 Hyaluronic acid binary mixtures and therapeutic use thereof
11/22/2007WO2007131538A1 Azepane- or azocane-substituted pyrazoline compounds, their preparation and use as medicaments
11/22/2007WO2007131517A1 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
11/22/2007WO2007131458A1 Process for the preparation of 2-(2-methyl-2-nitrovinyl)furan and its use for the treatment of diseases caused by ectoparasites
11/22/2007WO2007131446A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
11/22/2007WO2007131444A1 New crystallographic form of the compound 3,4',5-trihydroxyl-stilbene-3-beta-d-glucoside
1 ... 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508 ... 7860